100 6 24 18:00-20:00 11 13 1 APSC Subspecialty Congress Intervention Imaging 33 100 6
12 10-11 APSC 1. Symposium on PCI Guidelines 100 6 26 09:00-12:10 301 2. 100 7 2 09:00-17:00 4-5 slides 3. 2011 Board Review Course 100 7 10 08:00-17:00 101 4. 2011 Taiwan Society of Cardiology PAH CME- Pulmonary Arterial Hypertension Continuing Medical Education 100 7 31 14:00-17:50 Room 401 34
5. 2011 100 12 10-11 6. 42 APSC Intervention and Imaging 2012 Subspecialty Congress 101 5 4-6 1. 100 7 9-10 The Lancet JACC promote &APSC Subspecialty Congress 2. Live demo 1. 9/4 w7 09:00-12:00_ 101 1 18 20 10 / 5 / 5 Basic EP General 35 100 6
7 30 20 / 5 / 5 2 3 4 100.07.01 100.07.25 100.08.15 100.08.31 2. 7 1 100.07.01-102.06.30 3. 9/18 w7 09:00-14:00/ EKG_1 X _1 _1 PCI_1 ECHO_1 EP_1 General_1 4 10 36
1. 1 No. A9929 A9965 A9980 No. A99118 No. A9978 A99125 De novo No. No. A99100 2 No. A99132 No. A9920 No. A9976 A9979 A9986 A9992 A99111 A99126 No. A10019 No. A9984 A99117 A99120 A99123 A10036 3 No. A99104 A99116 A99127 A99130 A10002 A10007 A10009 No. A9978 A99125 No. A99109 No. A99114 A99128 A10006 A10029 37 100 6
1. PAOD Evaluation 1. Symptoms:Acute,chronic 2. PE,ABI,segmental pressure measurement 3. Duplex,IVUS 4. CTA 5. Angiography PAOD Treatment 1. Medical treatment: antiplatelet (aspirin), cilostazol,trental, analgesics, 2. PTA, with laser, with rota, with stent 3. Operation 4. Wound care 5. Amputation Consideration with Interventions 1. Assess difficulty: femoral punctures, peripheral artery puncture (e.g. popliteal, dorsalis pedis), Retrograde, Antegrade, cross-over 2. Multiple level lesions, multiple level interventions 3. Technical difficulty, especially for CTO, long lesions, resistant lesions, recoil problem, 4. Instruments: wire, balloon (may be very long), stent, laser 5. Technically difficult, time consuming, high costs Payment Now: 1. PTA 33074B-10,800 Iliac, 33133B-12,948 Carotid, 33128B-10,800 Cf: PTCA,33076A (1V) 44,000 33077A (2V) 60,000 33078A (3V) 76,000 PTMC,68029A,25,560 ASD occlusion 20,250 Angio (Extremities),7,500 38
Peripheral Committee's Suggestions: 1. 3 different segments as separate procedures (aortoiliac,femoropopliteal,infrapopliteal), also different limbs 2. PTA 33074B-10,800 with stent 33133B-12,948 3. For infrapopliteal,single a. intervention 33074B-10,800 multiple vessel intervention, 33074B-10,800 x 2 1 AV Shunt 2 Aortoiliac FemoropoplitealInfrapopliteal 3 Ankle-brachial Index Pulse Volume Recording or Duplex Multilevel Intervention Critical Limb Ischemia claudication Inflow Lesion iliac+/ - Femopopliteal 1~2 BTK lesion Critical Limb ischemia Tibial artery to foot Inflow lesion multilevel Intervention 4 2. " Q&A " Q&A 24 3. 17% 39 100 6
4. PCI Guidelines 1. 100 1 2 3 18 10 3/2 2/3 12 1 Congenital 2 CAD 3 Valve 4 Vascular 5 Basic & Others 3/1 6 1 Congenital 2 CAD 3 Valve 4 Vascular 5 Basic & Others Surgery of the Chest (Sabiston and Spencer)_2009 Cardiac Surger (Jone W. Kirklin)_2003 40
Cardiac Surgery in the Adult (Lawrence H. Cohn/McGraw-Hill ) _2007 AHA/ACC/ESC 2005 JNC-7 ATP III Heart Disease (Eugene Braunwald)_2008 The Heart (Hurst)_ 2008 100.06.30_ 100.07.25_ 100.08.15_ 100.08.30_ 3 8/13 w6 _ _ 8/27 w6 2010 4 6 3 2. 1. 41 100 6
2 45 1 31 1 2009 1~12 " " " 1 " 1. 2. 3. 4. 5.Median 6.Mean 7.SD 8.MAX 9.MIN 10. 2 PTPV 3 100 4 3 30 1. DRG 1 Device Physician Procedure Fee GDP pacemaker singe chamber $13,000 pacemaker NT single chamber Pacemaker single chamber 13,000 1 Pacemaker dual 15,600 1.2 CRT 26,000 2.0 ICD 22,100 1.7 CRT-D 18,200 1.4 Pacemaker D/S ratio 15,600 1.2 ICD/ Pacemaker ratio 22,100 1.7 CRT/Pacemaker ratio 26,000 2.0 CRT-D/ICD ratio 18,200 1.4 42
2 Device Follow-up Fee NT Pacemaker single chamber 1,000 With programming 1,000 Pacemaker dual camber 1,000 With programming 1,000 ICD-S 1,000 With programming 1,000 ICD-D 1,000 With programming 1,000 2. Syncope NT. 3,000 3. 1 St. Jude 2 physician fee Pacemaker single chamber NT. 13,000 4. 5. Isoproterenol 1/28 Isoproterenol 1 KOWA COMPANY, LTD 2 KOWA COMPANY, LTD 43 100 6
1. 1 + + / 5~6/1 2 1~1.5 2. ACLS Renewal Course 100.05.07 w6 4 13:00-17:00 Section 10/15 w6 3. 1 3.15 2 20 13 14 6 1. 1 Definition and diagnosis Diagnostic techniques Non-pharmacological management CRT, ICD Pharmacological therapy - ARB & ACI - -blocker 44
- - - Antithrombotic agents - Antiarrhythmic agents Surgery & surgical devices Acute heart failure Cardiac rehabilitation Therapeutic life-style changes Nutrition 2 pocket guideline 2 3 4 9/24 2. Optimal Medical Therapy of Heart Failure 1 9/24 w6 2 3. ESC_APSC Heart Failure Pilot Registry 4. - EF 5. 45 100 6
6. 1. topic 25 mins. + 15 mins. slides 1. 1 combine therapy 2 2001? 3 2. 2011 4 1 3. 4. 1 2011 2 210 46
5. PAH CME 1 1 Cardiologist aspect (EKG, ECHO. RHC and vasoreactivity test) 2 Pulmonologist aspect (CXR, blood gas, PFT, polysomnography) 3 Rheumatologist aspect 4 Pediatric cardiologist aspect (congenital HD, atrial septostomy) 5 Radiologist aspect (imaging diagnosis- MDCT, CXR, etc) 1 Medical therapy-focus on target therapy 2 Combination therapy 3 Surgeon aspect (Pulmonary endarectomy and transplantation) 2 7/31 w7 14:00-17:50_ Room 401 8/6 w6 14:00-17:50_ 4 8/7 w7 _ 9/25 w7 _ Advanced knowledge 10/2 w7 6. 2011 great debate 1 debate Adult ASD: to Close or Not? Combination Therapy: Initial or Sequential Combination? 2 12 PAH Satellite Symposium Dr. Gomberg plenary speech ECMO 47 100 6
1. 2. 3. 4. ECMO 5. 6. 7. 8. 9. 1. 2. 3. 4. 5. 6. 1. FiO2 1.0, PaO2< 60mmHg 2. 3. 1. Meconium aspiration syndrome 2. Hyaline membrane disease 3. Congenital diaphragm hernia 4. Persistent pulmonary hypertension of neonate 5. Oxygenation Index 40 OI MAP Mean Airway Pressure AaDO2= (PATM - 47) x FiO2 - PaO2 - PaCO2 48
> 610 for 8Hrs or >600 for 12Hrs PaO2 < 40mmHg for 2hrs 1. 2. 3. Airway surgery 4. 5. 30 1. 2. 2 The European Heart for Children Humanitarian Dinner during the ESC Congress EHC dinner, 29th August 2011, 8.30 pm, Paris City Hall (each table holds 10 seats; 160x10= 1600) 100 1 No. 1 49 100 6
2 3 4 5 2 No. 1 2 3 1 2 3 fellow training course 4 21M 25 50
5. 6 22M 25 7 / 1. 19 16 1 2 3 4 5 6 7 8 100.06.20 9 100.06.20 51 100 6
10 11 12 13 14 15 16 17 18 19 2. 53... 1 99.08.17 2 99.08.20 3 99.09.09 4 99.09.07 5 99.09.14 6 99.09.27 7 99.10.26 8 99.11.04 9 99.11.12 10 99.11.17 11 99.11.24 52
12 99.11.30 13 99.12.03 14 99.12.08 15 99.12.17 16 100.01.05 17 100.01.10 18 100.01.17 19 100.01.25 20 100.01.26 21 100.01.26 22 100.01.26 23 100.01.26 24 100.01.28 25 100.01.28 26 100.01.13 27 100.01.31 28 100.01.31 29 100.02.01 30 100.02.01 31 100.02.09 32 100.02.11 33 100.02.25 34 100.03.01 35 100.03.02 36 100.03.02 37 100.03.02 38 100.03.02 39 100.03.02 40 100.03.03 41 100.03.03 53 100 6
42 100.03.03 43 100.03.03 44 100.03.11 45 100.03.23 46 100.04.27 47 100.04.27 48 100.05.11 49 100.05.13 50 100.05.13 51 100.05.23 52 100.05.27 53 100.06.08 3. 1 1. 99.05.23 2. NT.3600 2 N0154 3 100.02.22 S0140 99 9 54
4.... 1. S1269 : - 96.11.06 / 96.07-99.07 /98.04-99.03_ 2. S1286 : - 97.11.06 / 97.07-99.06/ 3. S1018 : - 93.01.03 / 97.12-99.12/... 1 _ 100 2 _ 99.12.01-101.11.30 3 _ 99.10.01-101.09.30 4 _ 99.08.01-101.07.31 99.12.01 100 1 5 _ 6 100 100 2 101 2 101 55 100 6
1. 2. 1. Original 5 8 3 2 2. Case Report 3 2 1 3. 6 30 4. 5 56
98 10 1 8 APSC member of council meeting vice president 1 APSC fellowship 1/10 1 council meeting 2 2 APSC zone 2 vice president council member vice president 3 APSC council member vice president fellowship APSC council member vice president " " " " 57 100 6
promote APSC fellowship APSC fellowship APSC president vice president 58
"100 " " 1 The Heart Hurst 2008 2 Heart Disease Eugene Braunwald 2008 3 4 AHA/ ACC/ ESC 2005 JNC-7 ATP III 1 Moss' Heart Disease in Infants, Chlidren and Adolescents F.H.Abams, G.C.Emmanouilibes, T.A.Riemenschneider 2008 2 The Science and Practice of Pediatric Cardiology A Garson, JT Bricker, DJ Fisher, SR Neish 1998 3 AHA/ ACC/ ESC 2005 JNC-7 ATP III 59 100 6
100 100 7 1 7 20 10452 11 13 1 (1) (2) (3) (1) (2) (3) (4) 01353995 (5) 100 9 4 301 1 02-25976177~9#17 60
61 100 6
62
Optimal Medical Therapy of Heart Failure: Comparison of Current Practice Guidelines & the Best Strategies of Our Practices in Taiwan 100 9 24 13:30-17:35pm Time Topic Speaker 13:30~14:00 Reception 14:00~14:05 Opening Remarks 14:05~14:10 Introduction and Overview 14:10~14:30 ACEI / ARB Therapy 14:30~14:50 Beta Blocker Therapy 14:50~15:10 Diuretic Therapy 15:10~15:30 Coffee Break 15:30~15:50 Digitalis & Inotropic Therapy 15:50~16:10 Antithrombotic Therapy 16:10~16:30 Antiarrhythmic Therapy 16:30~16:50 Acute Heart Failure Therapy 16:50-17:10 Multidiscipline Care 17:10~17:30 Panel Discussion All faculties 17:30~17:35 Closing Remarks Learning Objectives: 1. List key practice guidelines ACC/AHA, ESC, HFSA, SIGN, NICE, etc. regarding pharmacological therapy in the care of patients with heart failure 2. How and why are they different from other guidelines? 3. New evidence based medicine in heart failure that are not listed in the guidelines 4. Best strategy of our practice in Taiwan 63 100 6
Agenda for 100/07/02 11 13 1 Time Topic Chair Speaker 09:00 Opening remarks 09:10 Applied anatomy 09:35 Q&A 09:50 Applied physiology and hemodynamics 10:15 Q&A 10:30 Cardiovascular symptomatology 10:55 Q&A 11:10 Break 11:40 Physical examination 12:05 Q&A 12:20 Clinical problem solving and differential diagnosis 12:45 Q&A 13:00 Lunch 13:30 Bedside teaching skill 13:55 Q&A 14:10 CXR and clinical correlation 14:35 Q&A 14:50 EKG and clinical correlation 15:15 Q&A 15:30 Echo and clinical correlation 15:55 Q&A 16:10 Panel discussion / 16:55 Closing remarks * 64